151 related articles for article (PubMed ID: 24520244)
1. Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.
Luo MN; Yao CW; Xu BH; Xu YZ; Liu WJ; Feng YM; Tao JL; Liu HF
Exp Ther Med; 2014 Mar; 7(3):553-559. PubMed ID: 24520244
[TBL] [Abstract][Full Text] [Related]
2. Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy.
Luo MN; Yin Y; Li S; Hao J; Yao C; Xu YZ; Liu HF; Yang L
Front Pharmacol; 2023; 14():1148553. PubMed ID: 37089927
[No Abstract] [Full Text] [Related]
3. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy.
Luo MN; Pan Q; Huang ZQ; Li SM; Xu YZ; Liu HF
Discov Med; 2020; 30(159):19-25. PubMed ID: 33357359
[TBL] [Abstract][Full Text] [Related]
5. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
[TBL] [Abstract][Full Text] [Related]
6. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
7. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
[TBL] [Abstract][Full Text] [Related]
8. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Tan M; Li W; Zou G; Zhang C; Fang J
Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
[TBL] [Abstract][Full Text] [Related]
10. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria in the prognosis of IgA nephropathy.
Aucella F; Netti GS; Piemontese M; Cincione IR; Infante B; Gesualdo L
Minerva Urol Nefrol; 2009 Sep; 61(3):235-48. PubMed ID: 19773725
[TBL] [Abstract][Full Text] [Related]
12. Histological Analysis of Serial Renal Biopsy Specimens from Children with Immunoglobulin A Nephropathy Not Treated with Immunosuppressants.
Yanai E; Yanagihara T; Itoh Y
J Nippon Med Sch; 2023; 90(3):253-261. PubMed ID: 37380476
[TBL] [Abstract][Full Text] [Related]
13. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
Cichoń-Kawa K; Mizerska-Wasiak M; Małdyk J; Turczyn A; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Sikora P; Gadomska-Prokop K; Grenda R; Pańczyk-Tomaszewska M
Pol Merkur Lekarski; 2018 Apr; 44(262):177-182. PubMed ID: 29775444
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies.
Li Y; Jiang S; Gao H; Yang Y; Liu X; Li W
Front Endocrinol (Lausanne); 2022; 13():1004289. PubMed ID: 36479219
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive agents for treating IgA nephropathy.
Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
[TBL] [Abstract][Full Text] [Related]
17. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy.
Alvarado AS; Andeen NK; Brodsky S; Hinton A; Nadasdy T; Alpers CE; Blosser C; Najafian B; Rovin BH
Nephrol Dial Transplant; 2018 Jul; 33(7):1168-1175. PubMed ID: 28992348
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
19. Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Kawasaki Y; Suyama K; Miyazaki K; Kanno S; Ono A; Suzuki Y; Sato M; Hashimoto K; Hosoya M
Nephrology (Carlton); 2014 Jul; 19(7):384-91. PubMed ID: 24646214
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
